A detailed history of Guyasuta Investment Advisors Inc transactions in Pfizer Inc stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 145,046 shares of PFE stock, worth $3.88 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
145,046
Previous 267,162 45.71%
Holding current value
$3.88 Million
Previous $7.48 Million 43.85%
% of portfolio
0.28%
Previous 0.51%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$27.7 - $31.39 $3.38 Million - $3.83 Million
-122,116 Reduced 45.71%
145,046 $4.2 Million
Q2 2024

Jul 22, 2024

SELL
$25.26 - $29.6 $78,129 - $91,552
-3,093 Reduced 1.14%
267,162 $7.48 Million
Q1 2024

Apr 16, 2024

SELL
$25.89 - $29.73 $46,239 - $53,097
-1,786 Reduced 0.66%
270,255 $7.5 Million
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $16.3 Million - $21.1 Million
-622,742 Reduced 69.6%
272,041 $7.83 Million
Q3 2023

Oct 25, 2023

SELL
$32.09 - $37.51 $68,800 - $80,421
-2,144 Reduced 0.24%
894,783 $29.7 Million
Q2 2023

Jul 17, 2023

SELL
$36.12 - $41.79 $356,973 - $413,010
-9,883 Reduced 1.09%
896,927 $32.9 Million
Q1 2023

Apr 28, 2023

BUY
$39.39 - $51.28 $327,567 - $426,444
8,316 Added 0.93%
906,810 $37 Million
Q4 2022

Jan 30, 2023

BUY
$41.75 - $54.5 $598,361 - $781,094
14,332 Added 1.62%
898,494 $46.1 Million
Q3 2022

Oct 25, 2022

BUY
$43.76 - $53.42 $123,315 - $150,537
2,818 Added 0.32%
884,162 $38.7 Million
Q2 2022

Jul 21, 2022

SELL
$46.53 - $55.17 $36,851 - $43,694
-792 Reduced 0.09%
881,344 $46.2 Million
Q1 2022

May 03, 2022

SELL
$45.75 - $56.69 $242,978 - $301,080
-5,311 Reduced 0.6%
882,136 $45.7 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $411,299 - $609,682
-9,954 Reduced 1.11%
887,447 $52.4 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $7,418 - $9,529
189 Added 0.02%
897,401 $38.6 Million
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $761,974 - $863,188
21,219 Added 2.42%
897,212 $35.1 Million
Q1 2021

May 11, 2021

BUY
$33.49 - $37.77 $1.02 Million - $1.15 Million
30,483 Added 3.61%
875,993 $31.7 Million
Q4 2020

Feb 08, 2021

BUY
$33.47 - $42.56 $203,564 - $258,849
6,082 Added 0.72%
845,510 $31.1 Million
Q3 2020

Oct 28, 2020

SELL
$31.75 - $37.25 $20,637 - $24,212
-650 Reduced 0.08%
839,428 $30.8 Million
Q2 2020

Aug 06, 2020

SELL
$30.12 - $36.54 $73,402 - $89,047
-2,437 Reduced 0.29%
840,078 $27.5 Million
Q1 2020

Apr 28, 2020

SELL
$27.03 - $38.62 $190,615 - $272,348
-7,052 Reduced 0.83%
842,515 $27.5 Million
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $790,475 - $897,088
24,012 Added 2.91%
849,567 $33.3 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $904,489 - $1.17 Million
27,839 Added 3.49%
825,555 $28.1 Million
Q2 2019

Aug 06, 2019

BUY
$36.98 - $41.52 $811,710 - $911,364
21,950 Added 2.83%
797,716 $34.6 Million
Q1 2019

May 10, 2019

SELL
$37.5 - $41.2 $291,562 - $320,330
-7,775 Reduced 0.99%
775,766 $32.9 Million
Q4 2018

Feb 11, 2019

BUY
$38.47 - $43.86 $92,674 - $105,658
2,409 Added 0.31%
783,541 $34.2 Million
Q3 2018

Nov 08, 2018

SELL
$34.47 - $41.81 $577,200 - $700,108
-16,745 Reduced 2.1%
781,132 $34.4 Million
Q2 2018

Aug 07, 2018

BUY
$32.98 - $35.16 $15,038 - $16,032
456 Added 0.06%
797,877 $28.9 Million
Q1 2018

May 09, 2018

BUY
$31.91 - $37.02 $756,490 - $877,633
23,707 Added 3.06%
797,421 $28.3 Million
Q4 2017

Feb 12, 2018

SELL
$33.26 - $35.29 $103,272 - $109,575
-3,105 Reduced 0.4%
773,714 $28 Million
Q3 2017

Nov 09, 2017

SELL
$31.0 - $34.15 $204,476 - $225,253
-6,596 Reduced 0.84%
776,819 $27.7 Million
Q2 2017

Aug 09, 2017

BUY
N/A
783,415
783,415 $26.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Guyasuta Investment Advisors Inc Portfolio

Follow Guyasuta Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.